Literature DB >> 32311768

M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.

Yuxin Shu1, Menghao Qin1, Yue Song1, Qing Tang1, Yahong Huang1, Pingping Shen1, Yan Lu1.   

Abstract

Macrophages are particularly abundant and play an important role throughout the tumor progression process, namely, tumor-associated macrophages (TAM) in the tumor microenvironment. TAM can be polarized to disparate functional phenotypes, the M1 and M2 macrophages. M1-like type macrophages are defined as pro-inflammatory cells involved in killing cancer cells, while M2-like type cells can specially promote tumor growth and metastasis, tissue remodeling and immunosuppression. In this study, we first found that integrin β3 was highly expressed on the surface of TAM, both in vivo and in vitro, that displayed the M2-like characteristics. Under intervention of CYC or triptolide, the integrin β3 inhibitors, the M2 polarization of TAM could be inhibited. Moreover, in the cell model of M2 polarization, either blockade or knockout/knockdown of integrin β3 could also suppress macrophage M2 polarization, which suggested that the M2 polarization was dependent on integrin β3. Using knockdown of peroxisome proliferator-activated receptor-γ (PPARγ), an M2 regulator, we found that expression and activation of PPARγ participated in M2 polarization that was mediated by integrin β3. Finally, to verify the activity of integrin β3 inhibitors on TAM in vivo, 4T1 tumor-bearing mice were treated with CYC or triptolide; in response, the M1/M2 ratio of TAM was up-regulated, while the infiltration of total lymphocytes into tumor tissue was not altered. In general, our study found a connection between integrin β3 and macrophage polarization, which provides a strategy for facilitating M2 to M1 repolarization and reconstructing the tumor immune microenvironment.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  M2 polarization; breast cancer; integrin β3; peroxisome proliferator-activated receptor-γ; tumor-associated macrophages

Mesh:

Substances:

Year:  2020        PMID: 32311768      PMCID: PMC7370165          DOI: 10.1111/imm.13196

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

Review 1.  Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.

Authors:  Muhammad Ovais; Mengyu Guo; Chunying Chen
Journal:  Adv Mater       Date:  2019-03-18       Impact factor: 30.849

2.  Differential Effects of Integrin αv Knockdown and Cilengitide on Sensitization of Triple-Negative Breast Cancer and Melanoma Cells to Microtubule Poisons.

Authors:  Nikolina Stojanović; Ana Dekanić; Mladen Paradžik; Dragomira Majhen; Krešimir Ferenčak; Jelena Ruščić; Irena Bardak; Christine Supina; Maja T Tomicic; Markus Christmann; Maja Osmak; Andreja Ambriović-Ristov
Journal:  Mol Pharmacol       Date:  2018-09-27       Impact factor: 4.436

3.  Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.

Authors:  Hui Hu; Genhua Huang; Haibin Wang; Xiaoli Li; Xiaobing Wang; Ying Feng; Buzhen Tan; Tingtao Chen
Journal:  Oncol Rep       Date:  2017-12-15       Impact factor: 3.906

4.  Tumour-infiltrating macrophages and clinical outcome in breast cancer.

Authors:  S M A Mahmoud; A H S Lee; E C Paish; R D Macmillan; I O Ellis; A R Green
Journal:  J Clin Pathol       Date:  2011-11-02       Impact factor: 3.411

5.  Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity.

Authors:  D Baeten; P Demetter; C Cuvelier; F Van Den Bosch; E Kruithof; N Van Damme; G Verbruggen; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

6.  Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF-7 cells.

Authors:  Huan Gao; Yue Zhang; Lei Dong; Xiao-Yu Qu; Li-Na Tao; Yue-Ming Zhang; Jing-Hui Zhai; Yan-Qing Song
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

7.  TAB1: a target of triptolide in macrophages.

Authors:  Yan Lu; Ya Zhang; Long Li; Xiujing Feng; Sen Ding; Wei Zheng; Jianxin Li; Pingping Shen
Journal:  Chem Biol       Date:  2014-01-23

8.  Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

Authors:  Jochen G Schneider; Yimin Zhu; Trey Coleman; Clay F Semenkovich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

9.  Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling.

Authors:  Chuxiao Zhang; Pengbo Cao; Aiqing Yang; Xia Xia; Yuanfeng Li; Mengting Shi; Ying Yang; Xiaojun Wei; Chun Yang; Gangqiao Zhou
Journal:  Carcinogenesis       Date:  2019-05-14       Impact factor: 4.944

10.  PI3Kγ is a molecular switch that controls immune suppression.

Authors:  Megan M Kaneda; Karen S Messer; Natacha Ralainirina; Hongying Li; Christopher J Leem; Sara Gorjestani; Gyunghwi Woo; Abraham V Nguyen; Camila C Figueiredo; Philippe Foubert; Michael C Schmid; Melissa Pink; David G Winkler; Matthew Rausch; Vito J Palombella; Jeffery Kutok; Karen McGovern; Kelly A Frazer; Xuefeng Wu; Michael Karin; Roman Sasik; Ezra E W Cohen; Judith A Varner
Journal:  Nature       Date:  2016-09-19       Impact factor: 49.962

View more
  10 in total

Review 1.  Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.

Authors:  Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

2.  Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization.

Authors:  Ji Eun Yu; In Jun Yeo; Dong Ju Son; Jaesuk Yun; Sang-Bae Han; Jin Tae Hong
Journal:  Mol Oncol       Date:  2021-12-20       Impact factor: 7.449

Review 3.  Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer.

Authors:  Giuseppina Augimeri; Luca Gelsomino; Pierluigi Plastina; Cinzia Giordano; Ines Barone; Stefania Catalano; Sebastiano Andò; Daniela Bonofiglio
Journal:  Int J Mol Sci       Date:  2020-12-19       Impact factor: 5.923

4.  Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.

Authors:  Yuanyuan An; Qing Yang
Journal:  Biomed Res Int       Date:  2020-12-10       Impact factor: 3.411

Review 5.  NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential.

Authors:  Kun Li; Tongyue Yao; Yu Zhang; Wen Li; Ziqiang Wang
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

6.  Associations of intermuscular adipose tissue and total muscle wasting score in PG-SGA with low muscle radiodensity and mass in nonmetastatic colorectal cancer: A two-center cohort study.

Authors:  Yang Wang; Yuliuming Wang; Guodong Li; Hao Zhang; Hang Yu; Jun Xiang; Zitong Wang; Xia Jiang; Guoqing Yan; Yunxiao Liu; Chunlin Wang; Huan Xiong; Guiyu Wang; Hanping Shi; Ming Liu
Journal:  Front Nutr       Date:  2022-08-25

Review 7.  The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.

Authors:  Huogang Wang; Mingo M H Yung; Hextan Y S Ngan; Karen K L Chan; David W Chan
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

8.  The Role of the Extracellular Matrix and Tumor-Infiltrating Immune Cells in the Prognostication of High-Grade Serous Ovarian Cancer.

Authors:  Yuri Belotti; Elaine Hsuen Lim; Chwee Teck Lim
Journal:  Cancers (Basel)       Date:  2022-01-14       Impact factor: 6.639

Review 9.  Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.

Authors:  Deyang Wu; Xiaowei Liu; Jingtian Mu; Jin Yang; Fanglong Wu; Hongmei Zhou
Journal:  Biomolecules       Date:  2022-03-02

10.  Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study.

Authors:  Qi Zhang; Meng-Meng Song; Xi Zhang; Jia-Shan Ding; Guo-Tian Ruan; Xiao-Wei Zhang; Tong Liu; Ming Yang; Yi-Zhong Ge; Meng Tang; Xiang-Rui Li; Liang Qian; Chun-Hua Song; Hong-Xia Xu; Han-Ping Shi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-08-02       Impact factor: 12.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.